244 related articles for article (PubMed ID: 34399854)
1. Forebrain Shh overexpression improves cognitive function and locomotor hyperactivity in an aneuploid mouse model of Down syndrome and its euploid littermates.
Gao FJ; Klinedinst D; Fernandez FX; Cheng B; Savonenko A; Devenney B; Li Y; Wu D; Pomper MG; Reeves RH
Acta Neuropathol Commun; 2021 Aug; 9(1):137. PubMed ID: 34399854
[TBL] [Abstract][Full Text] [Related]
2. Chronic up-regulation of the SHH pathway normalizes some developmental effects of trisomy in Ts65Dn mice.
Dutka T; Hallberg D; Reeves RH
Mech Dev; 2015 Feb; 135():68-80. PubMed ID: 25511459
[TBL] [Abstract][Full Text] [Related]
3. Chronic up-regulation of sonic hedgehog has little effect on postnatal craniofacial morphology of euploid and trisomic mice.
Singh N; Dutka T; Reeves RH; Richtsmeier JT
Dev Dyn; 2016 Feb; 245(2):114-22. PubMed ID: 26509735
[TBL] [Abstract][Full Text] [Related]
4. Size does not always matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal SAG treatment.
Gutierrez-Castellanos N; Winkelman BH; Tolosa-Rodriguez L; Devenney B; Reeves RH; De Zeeuw CI
J Neurosci; 2013 Sep; 33(39):15408-13. PubMed ID: 24068809
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
[TBL] [Abstract][Full Text] [Related]
6. APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome.
Trazzi S; Mitrugno VM; Valli E; Fuchs C; Rizzi S; Guidi S; Perini G; Bartesaghi R; Ciani E
Hum Mol Genet; 2011 Apr; 20(8):1560-73. PubMed ID: 21266456
[TBL] [Abstract][Full Text] [Related]
7. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
[TBL] [Abstract][Full Text] [Related]
8. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
[TBL] [Abstract][Full Text] [Related]
9. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M
Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-function mutation of c-Ret causes cerebellar hypoplasia in mice with Hirschsprung disease and Down's syndrome.
Ohgami N; Iizuka A; Hirai H; Yajima I; Iida M; Shimada A; Tsuzuki T; Jijiwa M; Asai N; Takahashi M; Kato M
J Biol Chem; 2021; 296():100389. PubMed ID: 33561442
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Stagni F; Raspanti A; Giacomini A; Guidi S; Emili M; Ciani E; Giuliani A; Bighinati A; Calzà L; Magistretti J; Bartesaghi R
Neurobiol Dis; 2017 Jul; 103():11-23. PubMed ID: 28359846
[TBL] [Abstract][Full Text] [Related]
13. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
[TBL] [Abstract][Full Text] [Related]
14. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
[TBL] [Abstract][Full Text] [Related]
15. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts.
Thomas JR; Sloan K; Cave K; Wallace JM; Roper RJ
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828335
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model.
Das I; Park JM; Shin JH; Jeon SK; Lorenzi H; Linden DJ; Worley PF; Reeves RH
Sci Transl Med; 2013 Sep; 5(201):201ra120. PubMed ID: 24005160
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome.
Giacomini A; Stagni F; Trazzi S; Guidi S; Emili M; Brigham E; Ciani E; Bartesaghi R
Neurobiol Dis; 2015 Oct; 82():385-396. PubMed ID: 26254735
[TBL] [Abstract][Full Text] [Related]
18. Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome.
Stagni F; Giacomini A; Emili M; Uguagliati B; Bonasoni MP; Bartesaghi R; Guidi S
Brain Pathol; 2019 May; 29(3):366-379. PubMed ID: 30325080
[TBL] [Abstract][Full Text] [Related]
19. Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression.
Fuchs C; Ciani E; Guidi S; Trazzi S; Bartesaghi R
Lab Invest; 2012 Nov; 92(11):1648-60. PubMed ID: 22890555
[TBL] [Abstract][Full Text] [Related]
20. Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes.
Hawley LE; Prochaska F; Stringer M; Goodlett CR; Roper RJ
Pharmacol Biochem Behav; 2022 Jun; 217():173404. PubMed ID: 35576991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
